In recent years, the importance of CD4+ T cells, particularly regulatory T (Treg) cells, in the pathophysiology of SSc has emerged as an important player both in immune disorders and in the fibrotic pathogenesis of SSc. This evidence concerns the gene CD4 and systemic sclerosis.